High Levels of Circulating Plasma Cells Are an Independent High-Risk Feature in Multiple Myeloma Patients and Their Prognostic Impact Is Modulated by the Achievement of Minimal Residual Disease Negativity
Proceedings article published in 2021 by
L. Bertamini 
,
P. Stefanoni,
P. Tacchetti,
A. Ledda,
A. Palmas,
M. Gentile,
S. Palmieri,
O. Annibali,
C. Musolino,
M. Burdisso
,
P. Stefanoni,
P. Tacchetti,
A. Ledda,
A. Palmas,
M. Gentile,
S. Palmieri,
O. Annibali,
C. Musolino,
M. Burdisso
